National Cervical Cancer Screening Program in France: Progress and Challenges
National Cervical Cancer Screening Program in France Progress and Challenges National Cervical Cancer Screening Program in France Established in 2018, the National Cervical Cancer Screening Program targets all women aged 25 to 65, including pregnant women, postmenopausal women, and women vaccinated against Human Papillomavirus (HPV). Each year, over 10 million women benefit from this […]
HPV vaccination and a future without cervical cancer
HPV vaccination and a future without cervical cancer Awareness-raising event for influencers and bloggers in Tajikistan — WHO Europe event on HPV vaccine introduction HPV vaccination vs cervical cancer WHO/Europe organized an event in Dushanbe (Tajikistan) with influencers and bloggers to support the upcoming introduction of the HPV vaccine in 2025. The goal was to […]
Global burden of cancer attributable to HIV
Global burden of cancer attributable to HIV A worldwide incidence analysis Cancer attributable to HIV Scientists from the International Agency for Research on Cancer (IARC) provide the first global assessment of the burden of cancer attributable to infection with HIV, in a new study published in The Lancet Global Health. The researchers also examined the burden […]
New IARC framework for regional cancer prevention codes
New IARC framework for regional cancer prevention codes Methodology released for developing regional Codes within the World Code Against Cancer Framework Cancer prevention codes IARC published a methodological document to support regions and countries in developing localized “Cancer Codes” within the broader World Code Against Cancer Framework. These codes aim to provide practical, evidence-based, and […]
IARC & JRC: first EU cervical cancer screening recommendations
IARC collaborates with the JRC to release first EU cervical cancer screening recommendations New guidelines to improve screening standards Cervical Cancer Screening IARC, in collaboration with the Joint Research Centre (JRC), published the first official set of recommendations for cervical cancer screening in the European Union. The guidelines suggest prioritizing HPV testing as the primary […]
EU Country Cancer Profiles 2025: Strategies in Europe
Climate action paired with Cancer Prevention Climate change mitigation and synergies with primary cancer prevention in Europe: time to implement opportunities Climate action for Cancer Prevention On 22 July 2025, IARC released a report highlighting the opportunities to align climate mitigation actions with primary cancer prevention in Europe. Based on the 4th Edition of the […]
IARC & JRC call for cervical cancer QA experts
IARC & JRC call for cervical cancer QA experts IARC and the European Commission’s JRC launch call for experts for quality assurance scheme for cervical cancer care QA On 23 July 2025, IARC and the European Commission’s Joint Research Centre launched a call for experts to develop a quality‑assurance (QA) scheme for cervical cancer care […]
Organized Cervical Cancer Screening Program in Hungary
Organized Cervical Cancer Screening Program in Hungary Since 2003, Hungary has operated an organized, population-based cervical cancer screening program aimed at the early detection and prevention of cervical cancer. The program targets women aged 25 to 65, who receive a personalized invitation letter every three years to attend the screening. The primary method of examination […]
New IARC Infographics on Cancer Risk Factors
New IARC Infographics on Cancer Risk Factors Subtitle: 20 updated visual tools on alcohol, smoking, diet, and prevention now available. Category: Awareness Date: 3 July 2025 The International Agency for Research on Cancer (IARC) has just releaseda set of 20 multilingual infographics summarizing key risk factors for cancer development: tobacco, alcohol, obesity, HPV infections, diet, […]
Hungary in the EUCanScreen Spotlight – July 2025
Hungary in the EUCanScreen Spotlight – July 2025 In July 2025, Hungary takes the spotlight in the EUCanScreen project, highlighting its commitment to the development and implementation of high-quality, evidence-based cancer screening programmes. As one of the participating countries in this joint action, Hungary contributes both strategic direction and practical expertise to the advancement of […]
